ARCHIVES

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

This article is from The Cancer Letter archive.

Vol. 20 No. 46 | December 2, 1994

Download PDF Visit The Full Archive

Related Articles

1991 Bypass Budget Would Fund 50 Percent Of Competing Grants

May 26, 1989

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Funding opportunities listed.

September 24, 2004

Olaparib Study Demonstrates No Changes In Overall Survival

March 30, 2012

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

NCI Awards 12 Grants For Planning of New Cancer Centers

March 27, 1992